Підписатись
Юлія Комісаренко
Юлія Комісаренко
Національний медичний університет імені О.О. Богомольця
Підтверджена електронна адреса в nmu.ua
Назва
Посилання
Посилання
Рік
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England journal of medicine 380 (24), 2295-2306, 2019
48962019
Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes
GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, P Rossing, P Kolkhof, ...
New England journal of medicine 383 (23), 2219-2229, 2020
14912020
Cardiovascular events with finerenone in kidney disease and type 2 diabetes
B Pitt, G Filippatos, R Agarwal, SD Anker, GL Bakris, P Rossing, A Joseph, ...
New England Journal of Medicine 385 (24), 2252-2263, 2021
7882021
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
R Agarwal, G Filippatos, B Pitt, SD Anker, P Rossing, A Joseph, P Kolkhof, ...
European heart journal 43 (6), 474-484, 2022
4182022
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
HC Gerstein, N Sattar, J Rosenstock, C Ramasundarahettige, R Pratley, ...
New England journal of medicine 385 (10), 896-907, 2021
3992021
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) study rationale, design, and baseline characteristics
MJ Jardine, KW Mahaffey, B Neal, R Agarwal, GL Bakris, BM Brenner, ...
American journal of nephrology 46 (6), 462-472, 2018
2402018
Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes
G Filippatos, SD Anker, R Agarwal, B Pitt, LM Ruilope, P Rossing, ...
Circulation 143 (6), 540-552, 2021
2252021
Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial
N Kobyliak, T Falalyeyeva, G Mykhalchyshyn, D Kyriienko, ...
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 12 (5), 617-624, 2018
1742018
Design and baseline characteristics of the finerenone in reducing cardiovascular mortality and morbidity in diabetic kidney disease trial
LM Ruilope, R Agarwal, SD Anker, GL Bakris, G Filippatos, C Nowack, ...
American journal of nephrology 50 (5), 345-356, 2019
1722019
Design and baseline characteristics of the finerenone in reducing kidney failure and disease progression in diabetic kidney disease trial
GL Bakris, R Agarwal, SD Anker, B Pitt, LM Ruilope, C Nowack, P Kolkhof, ...
American Journal of Nephrology 50 (5), 333-344, 2019
1502019
Finerenone reduces risk of incident heart failure in patients with chronic kidney disease and type 2 diabetes: analyses from the FIGARO-DKD trial
G Filippatos, SD Anker, R Agarwal, LM Ruilope, P Rossing, GL Bakris, ...
Circulation 145 (6), 437-447, 2022
1222022
Hyperkalemia risk with finerenone: results from the FIDELIO-DKD trial
R Agarwal, A Joseph, SD Anker, G Filippatos, P Rossing, LM Ruilope, ...
Journal of the American Society of Nephrology 33 (1), 225-237, 2022
1062022
Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes
G Filippatos, GL Bakris, B Pitt, R Agarwal, P Rossing, LM Ruilope, J Butler, ...
Journal of the American College of Cardiology 78 (2), 142-152, 2021
972021
Beneficial effects of probiotic combination with omega-3 fatty acids in NAFLD: a randomized clinical study
N Kobyliak, L Abenavoli, T Falalyeyeva, G Mykhalchyshyn, L Boccuto, ...
852018
Effect of SGLT2 inhibitors on stroke and atrial fibrillation in diabetic kidney disease
Z Zhou, MJ Jardine, Q Li, BL Neuen, CP Cannon, D De Zeeuw, ...
Stroke, 2021
712021
Ендокринологія
ПН Боднар, ЮІ Комісаренко, ГП Михальчишин, МІ Бобрик, ...
Нова Книга, 2020
652020
Vitamin D deficiency and immune disorders in combined endocrine pathology
YI Komisarenko, MI Bobryk
Frontiers in endocrinology 9, 387980, 2018
642018
Finerenone in patients with chronic kidney disease and type 2 diabetes by sodium–glucose cotransporter 2 inhibitor treatment: the FIDELITY analysis
P Rossing, SD Anker, G Filippatos, B Pitt, LM Ruilope, AL Birkenfeld, ...
Diabetes Care 45 (12), 2991-2998, 2022
632022
Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone
R Agarwal, SD Anker, G Bakris, G Filippatos, B Pitt, P Rossing, L Ruilope, ...
Nephrology Dialysis Transplantation 37 (6), 1014-1023, 2022
592022
Efficacy and safety of finerenone in patients with chronic kidney disease and type 2 diabetes by GLP‐1RA treatment: A subgroup analysis from the FIDELIO‐DKD trial
P Rossing, R Agarwal, SD Anker, G Filippatos, B Pitt, LM Ruilope, A Amod, ...
Diabetes, Obesity and Metabolism 24 (1), 125-134, 2022
472022
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20